© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jan 26, 2015, the consensus forecast amongst 42 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 23 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,530, with a high estimate of 1,758 and a low estimate of 1,250. The median estimate represents a 2.51% increase from the last price of 1,492.5. View Full Financials
In 2013, GlaxoSmithKline PLC reported a dividend of 0.78 GBP, which represents a 5.41% increase over last year. The 19 analysts covering the company expect dividends of 0.80 GBP for the upcoming fiscal year, an increase of 2.69%. View Full Financials
|Div growth (TTM)||+5.41%|
On Oct 22, 2014, GlaxoSmithKline plc reported 3rd quarter 2014 earnings of 0.279 per share. This result exceeded the 0.24 consensus of the 9 analysts covering the company and under-performed last year's 3rd quarter results by 3.46%.
The next earnings announcement is expected on Feb 04, 2015. View Full Interim Financials
|Average growth rate||+2.88%|
GlaxoSmithKline plc reported annual 2013 earnings of 1.12 per share on Feb 05, 2014.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 04, 2015. View Full Annual Financials
|Average growth rate||-1.42%|
GlaxoSmithKline plc had 3rd quarter 2014 revenues of 5.65bn. This missed the 5.75bn consensus estimate of the 9 analysts following the company. This was 1.53% above the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||-3.01%|
GlaxoSmithKline plc had revenues for the full year 2013 of 26.51bn. This was 0.28% above the prior year's results. View Full Annual Financials
|Average growth rate||-1.67%|